A Study to Find the Dose and Assess the Immune Response and Safety of a Vaccine Against Influenza in Healthy Younger and Older Adults

NCT06431607 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

845

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza, Human

Interventions

BIOLOGICAL: F2G22B/DL001Z
BIOLOGICAL: F2H23D/DL001Z-NH
BIOLOGICAL: F2H23B/DL001Z-NH
BIOLOGICAL: F2H23H/DL001Z
COMBINATION_PRODUCT: FDQ23A-NH (Flu D-QIV)
BIOLOGICAL: GSK5800544A
COMBINATION_PRODUCT: Flu D-TIV
BIOLOGICAL: F2H23A/DL001Z-NH
BIOLOGICAL: F2H23G/DL001Z
COMBINATION_PRODUCT: Fluzone HD Quadrivalent
COMBINATION_PRODUCT: Fluzone HD

Sponsor

GlaxoSmithKline